BOSUVI 500MG TAB is a prescription medication used to treat certain types of cancer, including:
- Chronic lymphocytic leukemia (CLL) in patients who have not responded to at least one prior therapy
- Acute lymphoblastic leukemia (ALL) in patients who have not responded to at least one prior therapy
It is a tyrosine kinase inhibitor that works by blocking the action of the SRC-kinase family, which are involved in the growth and spread of cancer cells.
Composition:
Each tablet of BOSUVI 500MG TAB contains 500mg of bosutinib.
Mechanism of Action:
Bosutinib works by:
- Blocking the action of the SRC-kinase family, which are involved in the growth and spread of cancer cells
- Inhibiting the formation of new blood vessels that feed the tumor
- Reducing the growth and proliferation of cancer cells
Uses:
BOSUVI 500MG TAB is used to treat certain types of cancer, including:
- Chronic lymphocytic leukemia (CLL) in patients who have not responded to at least one prior therapy
- Acute lymphoblastic leukemia (ALL) in patients who have not responded to at least one prior therapy
Dosage:
The recommended dosage of BOSUVI 500MG TAB is:
- 500mg taken orally once daily, with or without food
Side Effects:
Common side effects of BOSUVI 500MG TAB include:
- Diarrhea
- Fatigue
- Nausea and vomiting
- Abdominal pain
- Rash
- Constipation
- Decreased appetite
Recommendation:
BOSUVI 500MG TAB is recommended for patients who have not responded to previous therapy for their specific type of cancer. Patients should also be advised to monitor their liver function and kidney function regularly during treatment.
Important Note:
Patients should not take BOSUVI 500MG TAB if they have a history of severe allergic reactions, bleeding disorders, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as liver or kidney problems, before taking BOSUVI 500MG TAB.
Some common brands of bosutinib include:
- Bosulif (Pfizer)
- Bosutinib (Pfizer)
Please note that BOSUVI 500MG TAB is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.